Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IGC Pharma (IGC) Invested Capital (2016 - 2025)

Historic Invested Capital for Pharma (IGC) over the last 17 years, with Q3 2025 value amounting to $8.1 million.

  • Pharma's Invested Capital rose 969.23% to $8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year increase of 969.23%. This contributed to the annual value of $6.3 million for FY2025, which is 1353.64% down from last year.
  • According to the latest figures from Q3 2025, Pharma's Invested Capital is $8.1 million, which was up 969.23% from $6.1 million recorded in Q2 2025.
  • Pharma's 5-year Invested Capital high stood at $33.1 million for Q1 2021, and its period low was $6.1 million during Q2 2025.
  • For the 5-year period, Pharma's Invested Capital averaged around $16.3 million, with its median value being $14.1 million (2023).
  • Its Invested Capital has fluctuated over the past 5 years, first soared by 3569.32% in 2021, then crashed by 5090.2% in 2024.
  • Over the past 5 years, Pharma's Invested Capital (Quarter) stood at $29.5 million in 2021, then tumbled by 37.86% to $18.3 million in 2022, then crashed by 50.58% to $9.1 million in 2023, then plummeted by 30.86% to $6.3 million in 2024, then rose by 29.29% to $8.1 million in 2025.
  • Its Invested Capital was $8.1 million in Q3 2025, compared to $6.1 million in Q2 2025 and $6.3 million in Q1 2025.